Clinical Trials Directory

Trials / Completed

CompletedNCT02451813

The Relationship Between Needle Position and Injection Pressure During Femoral Nerve Block

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
St. Luke's-Roosevelt Hospital Center · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Recent evidence suggests that injection pressure monitoring may be able to predict needle nerve contact in the brachial plexus nerve block model, but little is known about multifascicular nerves. The investigators hypothesize that injection pressure monitoring can reliably predict needle-nerve contact during femoral nerve block.

Detailed description

Single center, observational study. Patients scheduled for elective lower limb surgery with femoral nerve block will be recruited. Femoral nerve will be identified using a linear ultrasound transducer. A 22 GA 5 cm nerve block needle will be inserted with bevel downward and advanced to the following conditions: 1. Needle tip slightly indenting the fascia iliaca lateral to the femoral nerve 2. Needle tip advanced through fascia iliaca 3. Needle tip slightly indenting the anterior surface of the femoral nerve 4. Needle tip withdrawn 1 mm from nerve. At each of these conditions, 1 ml of dextrose solution will be injected via an automated pump at 10 ml/min and the spread of injectate observed sonographically. Simultaneously, a blinded observer will measure opening injection pressure using both an electronic and a mechanical transducer. If opening pressure reaches 15 psi, this investigator will halt the injection. In addition, minimum threshold current required to elicit a motor response will be recorded for conditions 3 and 4. Patients will be contacted at 7 days and asked about any adverse effects.

Conditions

Interventions

TypeNameDescription
PROCEDUREApposition of needle bevel against femoral nerveIndentation of femoral nerve and fascia iliaca by block needle and measurement of opening injection pressure during the controlled injection of 1 ml of dextrose (D5W) solution

Timeline

Start date
2014-10-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2015-05-22
Last updated
2016-04-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02451813. Inclusion in this directory is not an endorsement.